Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
Public ClinicalTrials.gov record NCT00095316. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Adults admitted to intensive care units are at risk for a variety of complications. One of the most frequent complications is the development of new infections. Infections due to a fungus called Candida are of particular concern. This study will test the possibility that caspofungin, a new therapy for fungal infections, may reduce the rate of Candida infections in subjects at risk.
Study identification
- NCT ID
- NCT00095316
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2004
- Primary completion
- Not listed
- Completion
- Aug 31, 2006
- Last update posted
- Dec 4, 2014
2004 – 2006
United States locations
- U.S. sites
- 26
- U.S. states
- 19
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Hospital - Infectious Diseases | Birmingham | Alabama | 35249-0001 | — |
| University of Southern California - Infectious Diseases | Los Angeles | California | 90089-0121 | — |
| Harbor UCLA Medical Center - Medicine - Infectious Diseases | Torrance | California | 90502-2006 | — |
| University of Colorado Hospital - Denver | Denver | Colorado | 80220-3706 | — |
| MedStar Washington Hospital Center - Infectious Diseases | Washington D.C. | District of Columbia | 20010-3017 | — |
| Jackson Memorial Hospital | Miami | Florida | 33136-1005 | — |
| Emory University School of Medicine - Infectious Diseases | Atlanta | Georgia | 30303-3033 | — |
| Rush University Medical Center | Chicago | Illinois | 60612-3808 | — |
| University of Illinois at Chicago College of Medicine - Infectious Diseases | Chicago | Illinois | 60612-7300 | — |
| The University of Chicago - Medicine - Infectious Diseases & Global Health | Chicago | Illinois | 60637-1447 | — |
| Loyola University - Emergency Facility | Maywood | Illinois | 60153-3328 | — |
| Infectious Disease of Indiana, PSC | Indianapolis | Indiana | 46260-1992 | — |
| University of Kentucky - UK Albert B Chandler Hospital | Lexington | Kentucky | 40536-0001 | — |
| Overton Brooks VA Medical Center | Shreveport | Louisiana | 71101-4243 | — |
| Mark Hatfield Clinical Research Center | Bethesda | Maryland | 20892-0001 | — |
| Tufts Medical Center - Infectious Diseases Clinic | Boston | Massachusetts | 02111-1552 | — |
| University of Michigan - VA Ann Arbor Health Care Systems | Ann Arbor | Michigan | 48105-2303 | — |
| Harper University Hospital | Detroit | Michigan | 48201-2018 | — |
| Henry Ford Health System - Henry Ford Hospital | Detroit | Michigan | 48202-2608 | — |
| University of Mississippi - Infectious Diseases | Jackson | Mississippi | 39216-4505 | — |
| Cooper University Hospital - Infectious Diseases | Camden | New Jersey | 08103-1505 | — |
| Duke University Medical Center - Duke Clinical Research Institute | Durham | North Carolina | 27705-3824 | — |
| Memorial Hermann Hospital | Houston | Texas | 77030-1501 | — |
| University of Texas Health Science Center at San Antonio - Infectious Diseases | San Antonio | Texas | 78229-3901 | — |
| University of Virginia Primary Health Center - Infectious Diseases and International Health | Charlottesville | Virginia | 22908-1340 | — |
| University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology | Madison | Wisconsin | 53792-0001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095316, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2014 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00095316 live on ClinicalTrials.gov.